GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » EPS (Basic)

Intravenous Infusions (XGHA:IIL) EPS (Basic) : GHS (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions EPS (Basic)?

Intravenous Infusions's basic earnings per share (Basic EPS) for the six months ended in . 20 was GHS0.00. Intravenous Infusions does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Intravenous Infusions's EPS (Diluted) for the six months ended in . 20 was GHS0.00. Intravenous Infusions does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Intravenous Infusions's EPS without NRI for the six months ended in . 20 was GHS0.00. Intravenous Infusions does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Intravenous Infusions EPS (Basic) Historical Data

The historical data trend for Intravenous Infusions's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions EPS (Basic) Chart

Intravenous Infusions Annual Data
Trend
EPS (Basic)

Intravenous Infusions Semi-Annual Data
EPS (Basic)

Intravenous Infusions EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Intravenous Infusions's Basic EPS for the fiscal year that ended in . 20 is calculated as


Intravenous Infusions's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intravenous Infusions  (XGHA:IIL) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Intravenous Infusions EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.